HOT NEWS
Nycomed
NycomedNycomed is a privately owned pharmaceutical company that provides medicines for hospitals, specialists and general practitioners, as well as over-the-counter medicines in selected markets. The company is active in a range of therapeutic areas, focusing on gastroenterology, respiratory, inflammation, pain management, osteoporosis and surgical management. New products are sourced both from its own research and from business partners. Based in Europe, Nycomed is present in over 50 countries worldwide with increasing emphasis on fast-growing markets. The combined group employs 12,000 people. In 2007, it had annual sales of € 3.5 billion and an adjusted EBITDA of € 1.2 billion. For more information visit www.nycomed.com.

Nycomed RSS Channel

Filter     Display # 
# Article Title Hits
1 Nycomed on track in 2009 with strong growth in Key Products 214
2 Nycomed sustains commitment to Russia-CIS and invests in new pharmaceutical production plant 809
3 Nycomed reports sustained momentum in second quarter 2009 401
4 Nycomed to acquire local portfolio from Sanofi-Aventis and Zentiva 659
5 Nycomed's Instanyl® is first intranasal fentanyl approved in Europe 1278
6 Nycomed receives Marketing Authorization for Pantoprazole 20mg OTC from European Commission 1600
7 Nycomed Reports a Solid Start to 2009 453
8 Nycomed files European marketing authorisation application for Daxas® 835
9 Nycomed's Instanyl® receives positive CHMP opinion 1759
10 Nycomed reports a satisfactory 2008 580
11 Nycomed and EffRx have announced a licensing agreement on drug for the treatment of osteoporosis 678
12 Nycomed optimises its European manufacturing network 495
13 Nycomed's preclinical anti-cancer program sold to Bayer Schering Pharma 563
 
Bookmark and Share

Banner